CSL saw the highest growth of 105% in patent filings and 199% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 83% and grants by 124%. GlobalData’s DataBook provides a comprehensive analysis of CSL‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

CSL has been focused on protecting inventions in United States(US) with 15 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 26% filings and 17% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where CSL is filings its patents. Among the top granted patent authorities, CSL has 26% of its grants in European Patent Office(EPO), 17% in United States(US) and 9% in Australia(AU).

Regeneron Pharmaceuticals and Amgen could be the strongest competitors for CSL

Patents related to rare diseases and climate change lead CSL's portfolio

CSL has the highest number of patents in rare diseases followed by, climate change and nanomedicine. For rare diseases, nearly 50% of patents were filed and 62% of patents were granted in Q1 2024.

Blood coagulation related patents lead CSL portfolio followed by von willebrand disease (vwd), and graft versus host disease (gvhd)

CSL has highest number of patents in blood coagulation followed by von willebrand disease (vwd), graft versus host disease (gvhd), inflammation, and chronic kidney disease (chronic renal failure). For blood coagulation, nearly 3% of patents were filed and 7% of patents were granted in Q1 2024.

For comprehensive analysis of CSL's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.